Surgical treatment for carcinoma of the gastric cardia

a modified proximal esophagogastrectomy.

M. Valente, U. Pastorino, I. Cataldo, L. Bertario, M. Alloisio, G. Muscolino, G. Ravasi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Proximal esophagogastrectomy saving only the distal half of the greater curvature of the stomach was retrospectively evaluated in 91 consecutive patients with resectable carcinoma of the gastric cardia. Division of the right gastric artery at its beginning provided a free nodal margin if N1 diffusion was observed. Operative mortality was 6.5% and fatal leak rate 3.8%. Survival without dysphagia occurred in all but stage I tumors; for larger tumors recurrence and reflux esophagitis were not able to produce dysphagia because distant metastases were faster to kill the patients. Five-year survival was 0% for stage IV (i.e. incomplete macroscopic resection), 8% for stage III, 12% for stage II and 53% for stage I. Local recurrence occurred only at esophageal anastomosis and for every stage, whereas regional recurrence occurred only for tumors with nodal diffusion. The results of this study are not suitable for a comparison with total esophagogastrectomy by inductive logic, nevertheless deductive arguments are possible if patterns of recurrence are considered. The possibility of regional recurrence for N1 and not for N0 tumors means that the volume of nodal resection has diagnostic specificity for N0 but not for N1 tumors. If N2 nodal diffusion is really a sistemic disease, as indicated by current reports, than greater nodal resection by total esophagogastrectomy can only improve the diagnostic specificity of N1 assessment but not survival.

Original languageEnglish
Pages (from-to)575-580
Number of pages6
JournalTumori
Volume69
Issue number6
Publication statusPublished - Dec 31 1983

Fingerprint

Cardia
Stomach
Carcinoma
Recurrence
Deglutition Disorders
Survival
Neoplasms
Therapeutics
Peptic Esophagitis
Tumor Burden
Arteries
Neoplasm Metastasis
Mortality

ASJC Scopus subject areas

  • Cancer Research

Cite this

Valente, M., Pastorino, U., Cataldo, I., Bertario, L., Alloisio, M., Muscolino, G., & Ravasi, G. (1983). Surgical treatment for carcinoma of the gastric cardia: a modified proximal esophagogastrectomy. Tumori, 69(6), 575-580.

Surgical treatment for carcinoma of the gastric cardia : a modified proximal esophagogastrectomy. / Valente, M.; Pastorino, U.; Cataldo, I.; Bertario, L.; Alloisio, M.; Muscolino, G.; Ravasi, G.

In: Tumori, Vol. 69, No. 6, 31.12.1983, p. 575-580.

Research output: Contribution to journalArticle

Valente, M, Pastorino, U, Cataldo, I, Bertario, L, Alloisio, M, Muscolino, G & Ravasi, G 1983, 'Surgical treatment for carcinoma of the gastric cardia: a modified proximal esophagogastrectomy.', Tumori, vol. 69, no. 6, pp. 575-580.
Valente, M. ; Pastorino, U. ; Cataldo, I. ; Bertario, L. ; Alloisio, M. ; Muscolino, G. ; Ravasi, G. / Surgical treatment for carcinoma of the gastric cardia : a modified proximal esophagogastrectomy. In: Tumori. 1983 ; Vol. 69, No. 6. pp. 575-580.
@article{73297765f6224dfcadd5e92723c42921,
title = "Surgical treatment for carcinoma of the gastric cardia: a modified proximal esophagogastrectomy.",
abstract = "Proximal esophagogastrectomy saving only the distal half of the greater curvature of the stomach was retrospectively evaluated in 91 consecutive patients with resectable carcinoma of the gastric cardia. Division of the right gastric artery at its beginning provided a free nodal margin if N1 diffusion was observed. Operative mortality was 6.5{\%} and fatal leak rate 3.8{\%}. Survival without dysphagia occurred in all but stage I tumors; for larger tumors recurrence and reflux esophagitis were not able to produce dysphagia because distant metastases were faster to kill the patients. Five-year survival was 0{\%} for stage IV (i.e. incomplete macroscopic resection), 8{\%} for stage III, 12{\%} for stage II and 53{\%} for stage I. Local recurrence occurred only at esophageal anastomosis and for every stage, whereas regional recurrence occurred only for tumors with nodal diffusion. The results of this study are not suitable for a comparison with total esophagogastrectomy by inductive logic, nevertheless deductive arguments are possible if patterns of recurrence are considered. The possibility of regional recurrence for N1 and not for N0 tumors means that the volume of nodal resection has diagnostic specificity for N0 but not for N1 tumors. If N2 nodal diffusion is really a sistemic disease, as indicated by current reports, than greater nodal resection by total esophagogastrectomy can only improve the diagnostic specificity of N1 assessment but not survival.",
author = "M. Valente and U. Pastorino and I. Cataldo and L. Bertario and M. Alloisio and G. Muscolino and G. Ravasi",
year = "1983",
month = "12",
day = "31",
language = "English",
volume = "69",
pages = "575--580",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Surgical treatment for carcinoma of the gastric cardia

T2 - a modified proximal esophagogastrectomy.

AU - Valente, M.

AU - Pastorino, U.

AU - Cataldo, I.

AU - Bertario, L.

AU - Alloisio, M.

AU - Muscolino, G.

AU - Ravasi, G.

PY - 1983/12/31

Y1 - 1983/12/31

N2 - Proximal esophagogastrectomy saving only the distal half of the greater curvature of the stomach was retrospectively evaluated in 91 consecutive patients with resectable carcinoma of the gastric cardia. Division of the right gastric artery at its beginning provided a free nodal margin if N1 diffusion was observed. Operative mortality was 6.5% and fatal leak rate 3.8%. Survival without dysphagia occurred in all but stage I tumors; for larger tumors recurrence and reflux esophagitis were not able to produce dysphagia because distant metastases were faster to kill the patients. Five-year survival was 0% for stage IV (i.e. incomplete macroscopic resection), 8% for stage III, 12% for stage II and 53% for stage I. Local recurrence occurred only at esophageal anastomosis and for every stage, whereas regional recurrence occurred only for tumors with nodal diffusion. The results of this study are not suitable for a comparison with total esophagogastrectomy by inductive logic, nevertheless deductive arguments are possible if patterns of recurrence are considered. The possibility of regional recurrence for N1 and not for N0 tumors means that the volume of nodal resection has diagnostic specificity for N0 but not for N1 tumors. If N2 nodal diffusion is really a sistemic disease, as indicated by current reports, than greater nodal resection by total esophagogastrectomy can only improve the diagnostic specificity of N1 assessment but not survival.

AB - Proximal esophagogastrectomy saving only the distal half of the greater curvature of the stomach was retrospectively evaluated in 91 consecutive patients with resectable carcinoma of the gastric cardia. Division of the right gastric artery at its beginning provided a free nodal margin if N1 diffusion was observed. Operative mortality was 6.5% and fatal leak rate 3.8%. Survival without dysphagia occurred in all but stage I tumors; for larger tumors recurrence and reflux esophagitis were not able to produce dysphagia because distant metastases were faster to kill the patients. Five-year survival was 0% for stage IV (i.e. incomplete macroscopic resection), 8% for stage III, 12% for stage II and 53% for stage I. Local recurrence occurred only at esophageal anastomosis and for every stage, whereas regional recurrence occurred only for tumors with nodal diffusion. The results of this study are not suitable for a comparison with total esophagogastrectomy by inductive logic, nevertheless deductive arguments are possible if patterns of recurrence are considered. The possibility of regional recurrence for N1 and not for N0 tumors means that the volume of nodal resection has diagnostic specificity for N0 but not for N1 tumors. If N2 nodal diffusion is really a sistemic disease, as indicated by current reports, than greater nodal resection by total esophagogastrectomy can only improve the diagnostic specificity of N1 assessment but not survival.

UR - http://www.scopus.com/inward/record.url?scp=0021116843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021116843&partnerID=8YFLogxK

M3 - Article

VL - 69

SP - 575

EP - 580

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 6

ER -